This inventor holds 1 USPTO granted patent. Top assignee: Diqi Pharmaceuticals Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Jingyu He in Gastro-Retentive Drug Delivery Systems.
Introduction
Jingyu He is an accomplished inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. His innovative work focuses on enhancing the bioavailability and effectiveness of medications.
Latest Patents
Jingyu He holds a patent for a lenalidomide gastro-retentive sustained-release tablet and its preparation method. This invention discloses a sustained-release tablet that comprises 3 wt % to 14 wt % of lenalidomide, 14 wt % to 68 wt % of a release enhancer with low bulk density, and 23 wt % to 70 wt % of a sustained-release material with low bulk density. The formulation ensures that the tablet remains in a floating state within the gastric environment, thereby improving gastric retention and drug bioavailability while minimizing side effects.
Career Highlights
Jingyu He is associated with Diqi Pharmaceuticals Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been pivotal in developing new drug formulations that enhance patient outcomes.
Collaborations
Jingyu He has collaborated with notable colleagues, including Feng Liu and Huafeng Luo, to advance research and development in pharmaceutical technologies.
Conclusion
Jingyu He’s contributions to the field of gastro-retentive drug delivery systems exemplify the importance of innovation in pharmaceuticals. His work not only enhances drug efficacy but also improves patient safety and comfort.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile